These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7708982)
1. Optimizing nebulization practice within a large teaching hospital: easier said than done. Caldwell NA; Milroy R Respir Med; 1995 Jan; 89(1):57-9. PubMed ID: 7708982 [No Abstract] [Full Text] [Related]
5. [Good clinical practice in nebulization]. Dautzenberg B; Fauroux B; Bonfils P; Diot P; Faurisson F Ann Fr Anesth Reanim; 1998; 17 Suppl 2():31s-36s. PubMed ID: 9881205 [TBL] [Abstract][Full Text] [Related]
6. Aerosols as a way of treating patients. Clarke SW Eur J Respir Dis Suppl; 1986; 146():525-33. PubMed ID: 3536557 [No Abstract] [Full Text] [Related]
7. Inhalation Properties and Stability of Nebulized Naked siRNA Solution for Pulmonary Therapy. Tahara K; Hashimoto W; Takeuchi H Chem Pharm Bull (Tokyo); 2016; 64(1):63-7. PubMed ID: 26726746 [TBL] [Abstract][Full Text] [Related]
8. [Practice guidelines of aerosol therapy through nebulization. Proposals from the National Assizes on Nebulization, Paris, April 4-5, 1997 (version from September 15 1997)]. Arch Pediatr; 1998 Feb; 5(2):175-80. PubMed ID: 10223140 [TBL] [Abstract][Full Text] [Related]
9. Drugs by inhalatory route: an overview and upcoming clinical perspectives. Melillo EM; Balzano G Monaldi Arch Chest Dis; 1996 Oct; 51(5):405-12. PubMed ID: 9009629 [TBL] [Abstract][Full Text] [Related]
11. Nebulisation: techniques and care. Butler M Paediatr Nurs; 1998 Nov; 10(9):17-20. PubMed ID: 10085985 [No Abstract] [Full Text] [Related]
12. Respiratory drug delivery. Anderson PJ Chest; 1997 May; 111(5):1155-6. PubMed ID: 9149560 [No Abstract] [Full Text] [Related]
13. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: poor adherence and the need to address it. Duff AJ; Latchford GJ J Cyst Fibros; 2010 Dec; 9(6):455-6. PubMed ID: 20840889 [No Abstract] [Full Text] [Related]
14. Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy. Ari A; Fink JB Expert Rev Respir Med; 2011 Aug; 5(4):561-72. PubMed ID: 21859275 [TBL] [Abstract][Full Text] [Related]
15. Does nebulized corticosteroid therapy have an effect on ammonia-induced pulmonary injury? Hahn IH; Muhammad A J Toxicol Clin Toxicol; 2000; 38(1):79. PubMed ID: 10696931 [No Abstract] [Full Text] [Related]
16. Nebulization guidelines: The long wait is over! Katiyar SK; Katiyar S Indian J Tuberc; 2023 Oct; 70(4):379-382. PubMed ID: 37968041 [No Abstract] [Full Text] [Related]
17. Breathing easier: addressing the challenges of aerosolizing medications to infants and preschoolers. Goralski JL; Davis SD Respir Med; 2014 Aug; 108(8):1069-74. PubMed ID: 25012949 [TBL] [Abstract][Full Text] [Related]
18. Inhalation solutions--which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers--update 2013. Kamin W; Erdnüss F; Krämer I J Cyst Fibros; 2014 May; 13(3):243-50. PubMed ID: 24172851 [TBL] [Abstract][Full Text] [Related]
19. New guidelines conclude all aerosol therapy devices equally effective. School Nurse News; 2005 May; 22(3):9-10. PubMed ID: 15934537 [No Abstract] [Full Text] [Related]
20. Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine. Klyashchitsky BA; Owen AJ J Drug Target; 1999; 7(2):79-99. PubMed ID: 10617295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]